Your browser doesn't support javascript.
loading
The role of clonal communication and heterogeneity in breast cancer.
Martín-Pardillos, Ana; Valls Chiva, Ángeles; Bande Vargas, Gemma; Hurtado Blanco, Pablo; Piñeiro Cid, Roberto; Guijarro, Pedro J; Hümmer, Stefan; Bejar Serrano, Eva; Rodriguez-Casanova, Aitor; Diaz-Lagares, Ángel; Castellvi, Josep; Miravet-Verde, Samuel; Serrano, Luis; Lluch-Senar, María; Sebastian, Víctor; Bribian, Ana; López-Mascaraque, Laura; López-López, Rafael; Ramón Y Cajal, Santiago.
Afiliação
  • Martín-Pardillos A; Translational Molecular Pathology Group, Vall d'Hebron Research Institute, Barcelona, Spain. ana.martin@vhir.org.
  • Valls Chiva Á; CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Madrid, Spain. ana.martin@vhir.org.
  • Bande Vargas G; Translational Molecular Pathology Group, Vall d'Hebron Research Institute, Barcelona, Spain.
  • Hurtado Blanco P; Translational Molecular Pathology Group, Vall d'Hebron Research Institute, Barcelona, Spain.
  • Piñeiro Cid R; Cancer Modelling Lab, Roche-CHUS Joint Unit, Santiago de Compostela, Spain.
  • Guijarro PJ; CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Madrid, Spain.
  • Hümmer S; Cancer Modelling Lab, Roche-CHUS Joint Unit, Santiago de Compostela, Spain.
  • Bejar Serrano E; Translational Molecular Pathology Group, Vall d'Hebron Research Institute, Barcelona, Spain.
  • Rodriguez-Casanova A; Translational Molecular Pathology Group, Vall d'Hebron Research Institute, Barcelona, Spain.
  • Diaz-Lagares Á; CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Madrid, Spain.
  • Castellvi J; Translational Molecular Pathology Group, Vall d'Hebron Research Institute, Barcelona, Spain.
  • Miravet-Verde S; CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Madrid, Spain.
  • Serrano L; Cancer Epigenomics, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS), Santiago de Compostela, Spain.
  • Lluch-Senar M; CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Madrid, Spain.
  • Sebastian V; Cancer Epigenomics, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS), Santiago de Compostela, Spain.
  • Bribian A; Hospital Vall d'Hebron, Anatomía Patológica, Barcelona, Spain.
  • López-Mascaraque L; EMBL/CRG Systems Biology Research Unit, Centre for Genomic Regulation (CRG), The Institute of Science and Technology, Barcelona, Spain.
  • López-López R; EMBL/CRG Systems Biology Research Unit, Centre for Genomic Regulation (CRG), The Institute of Science and Technology, Barcelona, Spain.
  • Ramón Y Cajal S; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
BMC Cancer ; 19(1): 666, 2019 Jul 05.
Article em En | MEDLINE | ID: mdl-31277602
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Células Clonais / Heterogeneidade Genética Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Células Clonais / Heterogeneidade Genética Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Espanha